Literature DB >> 27541741

Synthesis of novel sulfonamides under mild conditions with effective inhibitory activity against the carbonic anhydrase isoforms I and II.

Erhan Başar1, Ekrem Tunca2, Metin Bülbül2, Muharrem Kaya2.   

Abstract

Novel sulfonamide derivatives 6a-i, as new carbonic anhydrase inhibitors which candidate for glaucoma treatment, were synthesized from the reactions of 4-amino-N-(4-sulfamoylphenyl) benzamide 4 and sulfonyl chloride derivatives 5a-i with high yield (71-90%). The structures of these compounds were confirmed by using spectral analysis (FT-IR, (1)H NMR, (13)C NMR, LC/MS and HRMS). The inhibition effects of 6a-i on the hydratase and esterase activities of human carbonic anhydrase isoenzymes, hCA I and II, which were purified from human erythrocytes with Sepharose®4B-l-tyrosine-p-aminobenzene sulfonamide affinity chromatography, were studied as in vitro, and IC50 and Ki values were determined. The results show that newly synthesized compounds have quite powerful inhibitory properties.

Entities:  

Keywords:  Amidation reaction; carbonic anhydrase; enzyme inhibition; glaucoma; sulfonamide

Mesh:

Substances:

Year:  2016        PMID: 27541741     DOI: 10.3109/14756366.2015.1134524

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  2 in total

1.  A novel proton transfer salt of 2-amino-6-sulfamoylbenzothiazole and its metal complexes: the evaluation of their inhibition effects on human cytosolic carbonic anhydrases.

Authors:  Zeynep Alkan Alkaya; Halil İlkimen; Cengiz Yenikaya; Yasemin Kaygısız; Metin Bülbül; Tuncay Tunç; Musa Sarı
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

2.  Synthesis and pharmacological effects of novel benzenesulfonamides carrying benzamide moiety as carbonic anhydrase and acetylcholinesterase inhibitors.

Authors:  Mehtap TuĞrak; Halise İnci GÜl; Barış Anil; İlhami GÜlÇİn
Journal:  Turk J Chem       Date:  2020-12-16       Impact factor: 1.239

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.